Abstract
To analyze the effect of prognostic variables and treatment factors on biochemical progression free survival (b-PFS) using a consecutive cohort of 4150 Iodine-125 low-dose-rate prostate brachytherapy (LDR-PB) monotherapy patients treated in a multi-centre, multi-practitioner setting.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
